Clinical Trial Update: Fade Upon TOF Stimulation Induced by Succinylcholine [Phase 4]

View source ↗

Summary

Phase 4 trial updating on fade upon TOF stimulation induced by succinylcholine; completed with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drugs 1000 Characters Limit Reached
• Drugs_corrected_placeholder
• Muscle Disorders
• Muscle Relaxant-related Placeholder Since No Specific Disease Indication Provided

Snippet

Sponsor: University of Toledo Health Science Campus | Conditions: Muscle Relaxants | Phase 4 | Status: COMPLETED | Results posted: 2018-01-02